© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Albendazole serves as a broad-spectrum anthelmintic used worldwide to manage intestinal worm infestations. First introduced in the mid-1970s, this compound gained a reputation in public health for tackling parasite control, especially in regions facing frequent outbreaks. The raw material presents itself in various physical forms based on its chemical processing—flaky solid, pearly granules, or fine crystalline powder. One often comes across albendazole packaged as a bulk industrial powder or in tablet forms in the pharmaceutical industry. Officially described under the HS Code 29332990, albendazole stands out due to its diverse utility and reliable molecular properties.
The empirical formula for albendazole is C12H15N3O2S, with a molecular weight of 265.33 g/mol. White to off-white in color, this compound appears as a crystalline or slightly pearly solid, though processing can alter its feel and texture. Albendazole has a melting point of around 208°C. The density floats close to 1.3 g/cm³, which helps when calculating storage or handling requirements in laboratory and industrial settings. Being almost insoluble in water, the powder won’t dissolve with ease but shows greater solubility in organic solvents like dimethyl sulfoxide, acetone, and chloroform. The low aqueous solubility impacts formulation choices during drug manufacturing, posing its own technical demands. When weighing or handling this material, the fine powder can disperse into the air, so breathing protection and sealed containment systems remain standard.
At the molecular level, albendazole features a benzimidazole ring fused with a substituted thioether group. Chemists recognize its 2-benzimidazolyl carbamate origin, which shapes both its therapeutic impact and chemical reactivity. The specific arrangement of atoms, with nitrogen-rich rings and sulfur-oxygen cycles, creates points of interest for synthetic modification and quality control assessment. This profile influences the way the substance interacts with living organisms; disrupting parasitic metabolism without overwhelming the host. Structural consistency ranks high for manufacturers who work to meet strict pharmacopoeial standards—whether selling to pharmaceutical giants or regional healthcare programs.
While albendazole primarily arrives as a solid, the manufacturing process can shape the raw material into various forms. Flakes and crystalline powders dominate the pharmaceutical supply chain. Pearly granules cater to high-volume compounding, where dosing accuracy becomes a concern. Occasionally, specialty formulations use microcrystalline or micronized albendazole to improve suspension in liquid media or to pack into capsules. Solutions of albendazole require robust solubilizers due to the poor water solubility, resulting in low-volume, high-concentration preparations mainly for research rather than direct administration. Density measurements and particle size analysis take on practical importance for automated dispensing lines and for regulatory documentation supporting safe and consistent end-use.
Despite its world-changing role in treating parasitic infections, albendazole requires careful handling as a chemical raw material. Contact with the undiluted powder can provoke skin and respiratory irritation. Chronic laboratory exposure may cause headaches or dizziness, and the compound carries teratogenic risks after sustained or high-level exposure. Personnel need to work with gloves, safety goggles, and masks in well-ventilated environments. Material Safety Data Sheets (MSDS) classify albendazole as slightly hazardous in case of ingestion, inhalation, or skin contact. Environmental protocols insist on proper disposal and spill cleanup, since excess release could disrupt water systems or soil microbes. Drug manufacturing facilities use fume hoods, dust extractors, and spill containment gear to prevent accidents and long-term health problems for workers.
Production begins with high-purity intermediates, such as benzimidazole and methyl thioethers, often sourced from major chemical suppliers in China, India, or Europe. Pharmaceutical-grade synthesis demands precise analytical tracking to ensure minimal contaminant and impurity content. Supply chain traceability concerns arise around quality differences between suppliers, batch consistency, and secure transport to prevent degradation. Each kilogram of albendazole often undergoes spectroscopic validation, chromatographic purity checks, and density verification before shipment for large-scale tablet or liquid suspension production. This rigorous pipeline bolts onto a larger strategy for keeping the chemical as safe and effective as possible from raw material stage to finished drug format.
In nearly every country, albendazole underpins parasite control for both humans and livestock. Global health agencies rely on affordable access while environmentalists highlight risks in residues entering ecosystems. Some recent projects look to develop biodegradable packaging, minimize solvent waste, and improve worker safety with enclosed automation. The WHO and several non-governmental organizations continue to distribute albendazole tablets as part of mass deworming programs, focusing on safe use and nutritional support for vulnerable populations. Efforts to green the manufacturing supply chain carry extra weight in regions with limited regulatory oversight. Making albendazole production less resource-intensive helps support long-term global health outcomes alongside environmental stewardship.
